• SENSEX 74,902.57
    373.49 (+0.50%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Meesho
    230.80 125.70(%)
  • Allied Blenders
    667.75 719.95(%)
  • Escorts Kubota
    2,828.00 3,998.95(%)
  • Molbio Diagnosti
    1,338.00 1,686.50(%)
  • Swiggy
    279.80 235.85(%)
  • Ather Energy
    1,484.00 535.00(%)
  • Kanohar Elect.
    938.00 905.50(%)
  • Ola Electric
    42.32 59.20(%)
  • Tour. Fin. Corp.
    143.00 148.00(%)
  • Glass Wall Syst.
    296.00 185.05(%)
  • HDFC Bank
    742.80 1,020.35(%)
  • Cupid
    268.35 298.95(%)
  • Eternal
    344.75 368.40(%)
  • PC Jeweller
    14.87 14.45(%)
  • Elecon Engg.Co
    476.90 628.45(%)
  • Solar Industries
    20,362.20 22,630.05(%)
  • Cholaman.Inv.&Fn
    1,783.85 1,952.00(%)
  • Wockhardt
    2,359.60 2,420.00(%)
  • IDFC First Bank
    89.58 88.70(%)
  • Bluestone Jewel
    845.35 400.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Natco Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco
  • BSE Code : 4684.0
  • ISIN : INE987B01026
815.05 -1 (-0.15%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    806.10

  • Today’s High

    820.00

  • Open

    819.30

  • Perv Close

    816.30

  • 52W Low

    789.00

  • 52W High

    1,226.80

Key Indicators

  • P/E(TTM)

    16.36

  • Mar.Cap (₹Cr.)

    14,598.35

  • Div & Yield %

    0.61

  • Book Value(₹)

    477.51

  • Debt-Equity Ratio

    -0.15

  • AGM Date

    22-Sep-2026

  • EPS

    49.80

  • P/E Ratio

    16.36

Financials Ratios

  • Debt-Equity Ratio

    0.05

  • Mar.Cap (₹Cr.)

    14,598.35

  • RONW (%)

    25.88

  • ROCE (%)

    29.63

Score Board

  • Equity (₹ in Cr.)

    35.82

  • BV (₹)

    477.50

  • Sales( ₹ in Cr.)

    3,594.60

  • NP (in Cr.)

    1,299.73

  • NP Var(%)

    -26.0

  • Div%

    250.0

  • CPS (₹)

    83.20

  • EPS (₹)

    72.60

  • Traded Value (₹ in Lakhs)

    14,596.56

  • 52 Week High

    1,226.80

  • 52 Week Low

    789.00

  • Price BSE

    815.0

  • Price NSE

    815.00

  • Market Capital( in Cr.)

    14,596.56

  • P/C Ratio

    9.80

  • P/E Ratio

    11.20

  • Price Vs.BV

    72.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 3,594.60 4,094.50 3,568.90 2,351.00 1,767.80 1,653.50
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,594.60 4,094.50 3,568.90 2,351.00 1,767.80 1,653.50
Other Income 281.10 321.30 104.70 85.50 94.60 101.10
Stock Adjustments 69.20 -11.60 -17.20 -34.60 5.50 46.90
Total Income 3,944.90 4,404.20 3,656.40 2,401.90 1,867.90 1,801.50
EXPENDITURE :            
Raw Materials 642.90 581.70 557.30 495.10 540.10 546.90
Power and Fuel Cost 96.90 93.10 88.90 81.90 76.40 59.40
Employee Cost 591.70 515.30 454.90 425.70 410.10 380.00
Other Manufacturing Expenses 279.90 217.70 179.80 150.30 148.70 114.30
Selling and Administration Expenses 618.50 444.10 483.70 290.70 309.10 140.30
Miscellaneous Expenses 129.00 86.70 150.10 28.00 75.90 41.90
Employee Benefit Expenses 591.70 515.30 454.90 425.70 410.10 380.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,358.90 1,938.60 1,914.70 1,471.70 1,560.30 1,282.80
Operating Profit 1,586.00 2,465.60 1,741.70 930.20 307.60 518.70
Interest 32.30 19.60 14.50 8.60 13.30 11.30
Gross Profit 1,553.70 2,446.00 1,727.20 921.60 294.30 507.40
Depreciation 189.60 220.00 171.90 150.90 138.40 115.20
Profit Before Tax 1,364.10 2,226.00 1,555.30 770.70 155.90 392.20
Current Tax 268.40 407.50 284.80 133.10 32.50 93.30
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -185.80 -31.90 -36.10 0.50 -15.70 -10.60
Reported Net Profit 1,281.50 1,850.40 1,306.60 637.10 139.10 309.50
Extraordinary Items -18.23 104.58 -2.12 14.71 33.80 24.39
Adjusted Net Profit 1,299.73 1,745.82 1,308.72 622.39 105.30 285.11
Adjustment below Net Profit 15.30 3.00 -49.70 -1.00 0.40 2.20
P & L Balance brought forward 5,972.20 4,226.30 3,134.60 2,587.10 2,520.50 2,322.50
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 89.60 107.50 165.20 88.60 72.90 113.90
P & L Balance carried down 7,179.40 5,972.20 4,226.30 3,134.60 2,587.10 2,520.30
Dividend 0.00 0.00 170.20 100.40 82.10 113.90
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 250.00 300.00 475.00 275.00 225.00 262.50
Dividend Per Share(Rs) 5.00 6.00 9.50 5.50 4.50 5.25
Earnings Per Share-Unit Curr 71.59 103.37 72.99 34.91 7.62 16.96
Earnings Per Share(Adj)-Unit Curr 71.59 103.37 72.99 34.91 7.62 16.96
Book Value 477.80 409.72 312.42 257.64 229.69 224.17
Book Value(Adj)-Unit Curr 477.80 409.72 312.42 257.64 229.69 224.17

Shareholding Pattern

  • Promoter Group

    49.42%

  • Public Share Holding

    50.58%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 491,761 491,761.00 491,761 491,761
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 491,761 0.27 491,761 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 37,756,220 21.08 37,756,220 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50,267,145 28.07 50,267,145 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 88,023,365 49.14 88,023,365 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 385 0.00 385 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 25 0.00 25 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 30,426,728 16.99 30,426,728 245
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,511,814 3.64 6,511,814 15
Mutual Funds / UTI 3,438,241 1.92 3,438,241 24
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 117,605 0.07 117,605 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 40,494,798 22.61 40,494,798 298
2] Non Institution
Bodies Corporate 2,737,131 1.53 2,734,131 1,015
Clearing Members 154 0.00 154 3
Directors of their Relatives 120,223 0.07 120,223 7
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,044,119 1.70 3,043,619 10,363
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,046,252 0.58 1,046,152 3,676
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,823,745 3.25 5,823,745 17
Individuals holding nominal share capital up to Rs. 1 lakh 36,107,997 20.16 35,781,897 387,621
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,752 0.00 1,752 4
Others 862,578 0.48 862,578 2
Sub Total 50,099,946 27.97 49,770,246 402,846
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 179,109,870 100.00 178,780,170 403,166

Company Background

Natco Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco Pharma Ltd
  • BSE Code : 4684.0
  • ISIN : INE987B01026

  • Incorporation Year

    1981

  • Registered Office

    Natco House
    Road No 2 Banjara Hills, Hyderabad,
    Telangana-500033

  • Telephone

    91-040-23547532

  • FAX

    91-040-23548243

  • Chairman

    V C Nannapaneni

  • Managing Director

  • Company Secretary

    Chekuri Venkat Ramesh

  • Auditor

    B S R & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Natco Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Natco Pharma 814.95 3,875.70 3,594.60 16.36 16.42
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77